Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Show all posts
Showing posts with label MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Show all posts
Thursday, August 3, 2017

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

›
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a com...
Wednesday, August 2, 2017

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

›
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a com...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.